Delivery Order SPE2DR25D3103-SPE2DR26F9V17
Award Date 1/7/26
Potential Completion Date 1/8/26
Potential Value $17K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $12.76K delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of November 14, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, representing the type of specialized...
- The Defense Logistics Agency awarded a delivery order valued at $20,721.48 to AmerisourceBergen Drug Corp for the supply of Vemlidy 25 mg tablets (30-count units) on October 28, 2025, with completion scheduled for October 29, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic...
- The Defense Logistics Agency awarded a $40,852.26 delivery order to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units. This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of July 24, 2025, with performance to take place at the vendor's location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used primarily in the treatment of chronic hepatitis B, reflecting the Defense...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,624.87 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (quantity 30) on December 19, 2025, with completion expected by December 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's corporate office in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, representing the...
- The Defense Logistics Agency awarded a $3,914.81 delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on July 14, 2025, with an ultimate completion date of July 15, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is being performed at the contractor's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication used in hepatitis B treatment, representing part of the Defense...
- The Defense Logistics Agency awarded a $50.8K delivery order to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (quantity: 30 units) on November 28, 2025, with completion scheduled for December 1, 2025. This firm fixed price delivery order was awarded competitively with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. Vemlidy is an antiviral medication used in the treatment of chronic hepatitis B, representing one of numerous...
- The Defense Logistics Agency awarded a delivery order valued at $8,204.95 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units) on December 2, 2025, with completion expected by December 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor's corporate office located in Conshohocken, Pennsylvania. Vemlidy is a prescription antiviral medication used in hepatitis B treatment, reflecting the Defense...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Vemlidy 25 mg tablets in quantities of 30 units, with a ceiling value of $5,733.84. This is a firm fixed-price delivery order with no set-aside designation, issued as a competitive award. The contract is set to be completed by November 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral...
- On January 8, 2026, the Defense Logistics Agency awarded a delivery order valued at $18,972.34 to AmerisourceBergen Drug Corp for Vemlidy 25 mg tablets (30-count units). This firm fixed-price, non-set-aside contract is scheduled for completion by January 9, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerisourceBergen's parent company, Cencora, Inc.'s, larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $12,079.93 to AmerisourceBergen Drug Corp on May 6, 2025, for the supply of Vemlidy 25 mg tablets (30-count unit). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of May 7, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Vemlidy is an antiviral medication primarily used in the treatment of chronic hepatitis B, representing the type of...